4.2 Article

Breast milk and in utero transmission of HIV-1 select for envelope variants with unique molecular signatures

Journal

RETROVIROLOGY
Volume 14, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/s12977-017-0331-z

Keywords

HIV-1; Mother-to-child transmission; Envelope; CD4; Glycosylation; Broadly neutralizing antibodies

Categories

Funding

  1. National Institutes of Health Cellular, Biochemical, and Molecular Sciences Training Program Grant [T32 067587]
  2. National Institute of Child Health and Human Development [RO1 HD 39611, RO1 HD 40777]
  3. International Maternal Pediatric Adolescent AIDS Trials Group [U01 A1068632]
  4. National Institute of Allergy and Infectious Diseases [R37 AI047734]
  5. Seattle Center for AIDS Research Molecular Profiling and Computational Biology Core [P30 AI027757]

Ask authors/readers for more resources

Background: Mother-to-child transmission of human immunodeficiency virus-type 1 (HIV-1) poses a serious health threat in developing countries, and adequate interventions are as yet unrealized. HIV-1 infection is frequently initiated by a single founder viral variant, but the factors that influence particular variant selection are poorly understood. Results: Our analysis of 647 full-length HIV-1 subtype C and G viral envelope sequences from 22 mother-infant pairs reveals unique genotypic and phenotypic signatures that depend upon transmission route. Relative to maternal strains, intrauterine HIV transmission selects infant variants that have shorter, less-glycosylated V1 loops that are more resistant to soluble CD4 (sCD4) neutralization. Transmission through breastfeeding selects for variants with fewer potential glycosylation sites in gp41, are more sensitive to the broadly neutralizing antibodies PG9 and PG16, and that bind sCD4 with reduced cooperativity. Furthermore, experiments with Affinofile cells indicate that infant viruses, regardless of transmission route, require increased levels of surface CD4 receptor for productive infection. Conclusions: These data provide the first evidence for transmission route-specific selection of HIV-1 variants, potentially informing therapeutic strategies and vaccine designs that can be tailored to specific modes of vertical HIV transmission.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available